The genome editing market is projected to grow at a CAGR of 12.39% during the forecast period, reaching a total market size of US$6.385 billion in 2024 from US$3.168 billion in 2018. An increment in R&D consumption and development of biotechnology and pharmaceutical businesses will likewise impel market development.